|
Sample name
|
Virus
|
Host
|
PVL
|
Template μg
|
Raw reads
|
Chimeric reads (%)
|
Pure host / pure viral reads
|
Insertion sites
|
Largest clone (%)
|
|---|
|
ATL2
|
HTLV-1
|
HSA
|
nd
|
4
|
81,219
|
68.21
|
0.0037 / 31.8
|
160
|
49.5
|
|
ATL100
|
HTLV-1
|
HSA
|
106
|
4
|
4838
|
64.14
|
9.16 / 26.7
|
13
|
89.624
|
|
233
|
BLV
|
OAR
|
78.3
|
7
|
524,698
|
53.4
|
0.04 / 46.53
|
5311
|
5.22
|
|
221 (022016)
|
BLV
|
OAR
|
63
|
4
|
180,276
|
67.14
|
3.59 / 29.27
|
8023
|
0.625
|
|
221 (032014)
|
BLV
|
OAR
|
16
|
4
|
32,266
|
68.69
|
0.11 / 31.20
|
5374
|
0.279
|
|
220
|
BLV
|
OAR
|
3.8
|
2
|
44,876
|
67.38
|
0 / 32.62
|
1352
|
3.55
|
|
1439
|
BLV
|
BosT
|
45
|
3
|
181,055
|
70.52
|
0.19 / 29.29
|
5773
|
1.17
|
|
560
|
BLV
|
BosT
|
0.644
|
1
|
6802
|
69.83
|
1.12 / 29.06
|
172
|
4.59
|
|
1053
|
BLV
|
BosT
|
23.5
|
6
|
367,454
|
72.13
|
0.04 / 27.83
|
17,903
|
0.353
|
|
HIV_U1
|
HIV-1
|
HSA
|
200
|
2
|
94,086
|
54.66
|
2.75 / 42.59
|
728
|
47.2
|
|
Jurkat U1–0.1
|
HIV-1
|
HSA
|
0.2
|
5
|
252,913
|
43.33
|
0.04 / 56.62
|
4
|
71.7
|
|
Jurkat U1–0.01
|
HIV-1
|
HSA
|
0.02
|
5
|
234,421
|
43.33
|
0.04 / 56.52
|
2
|
90.2
|
|
Jurkat neg
|
HIV-1
|
HSA
|
0
|
5
|
12,137
|
0
|
100 / 0
|
0
|
0
|
|
02006
|
HIV-1
|
HSA
|
0.46
|
12
|
240,641
|
51.63
|
1.10 / 47.27
|
158
|
7.82
|
|
06042
|
HIV-1
|
HSA
|
0.56
|
8
|
226,685
|
21.18
|
0.41 / 78.41
|
73
|
4.77
|
|
HPV18_PX
|
HPV18
|
HAS
|
nd
|
4
|
180,550
|
21.36
|
0.29 / 78.35
|
55
|
nd
|
|
HPV18_PY
|
HPV18
|
HAS
|
nd
|
4
|
82,807
|
0.09
|
0.05 / 99.86
|
19
|
nd
|
- Chimeric reads reads containing host and viral DNA, cover the integration site, Pure host/pure viral reads reads containing either host or viral DNA, do not include the integration site, Largest clone % insertion site with highest number of reads in that sample, PVL proviral load. (Percentage cells carrying a single copy of integrated provirus or number proviral copies per 100 cells)
